Inhibikase Therapeutics Inc (IKT)
1.485
-0.10
(-6.60%)
USD |
NASDAQ |
Apr 30, 16:00
1.485
0.00 (0.00%)
After-Hours: 20:00
Inhibikase Therapeutics Market Cap: 9.752M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 10.44M |
| April 26, 2024 | 11.23M |
| April 25, 2024 | 12.48M |
| April 24, 2024 | 12.28M |
| April 23, 2024 | 10.38M |
| April 22, 2024 | 8.996M |
| April 19, 2024 | 13.40M |
| April 18, 2024 | 13.79M |
| April 17, 2024 | 13.99M |
| April 16, 2024 | 13.96M |
| April 15, 2024 | 14.41M |
| April 12, 2024 | 14.38M |
| April 11, 2024 | 14.78M |
| April 10, 2024 | 14.12M |
| April 09, 2024 | 13.99M |
| April 08, 2024 | 14.51M |
| April 05, 2024 | 14.45M |
| April 04, 2024 | 14.45M |
| April 03, 2024 | 14.12M |
| April 02, 2024 | 14.12M |
| April 01, 2024 | 14.18M |
| March 28, 2024 | 13.99M |
| March 27, 2024 | 14.90M |
| March 26, 2024 | 14.83M |
| March 25, 2024 | 14.31M |
| Date | Value |
|---|---|
| March 22, 2024 | 14.44M |
| March 21, 2024 | 14.31M |
| March 20, 2024 | 13.28M |
| March 19, 2024 | 12.50M |
| March 18, 2024 | 13.02M |
| March 15, 2024 | 13.67M |
| March 14, 2024 | 13.80M |
| March 13, 2024 | 14.44M |
| March 12, 2024 | 14.70M |
| March 11, 2024 | 15.74M |
| March 08, 2024 | 16.00M |
| March 07, 2024 | 15.67M |
| March 06, 2024 | 15.61M |
| March 05, 2024 | 15.41M |
| March 04, 2024 | 14.57M |
| March 01, 2024 | 13.93M |
| February 29, 2024 | 13.36M |
| February 28, 2024 | 13.73M |
| February 27, 2024 | 13.98M |
| February 26, 2024 | 13.73M |
| February 23, 2024 | 13.24M |
| February 22, 2024 | 13.49M |
| February 21, 2024 | 13.73M |
| February 20, 2024 | 14.10M |
| February 16, 2024 | 14.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.342M
Minimum
Oct 09 2023
99.50M
Maximum
Dec 23 2020
30.28M
Average
21.54M
Median
Market Cap Benchmarks
| Tenax Therapeutics Inc | 7.617M |
| BioRestorative Therapies Inc | 9.546M |
| Bio-Path Holdings Inc | 1.921M |
| ADMA Biologics Inc | 1.488B |
| Hepion Pharmaceuticals Inc | 7.661M |
Market Cap Related Metrics
| Price to Book Value | 0.8883 |
| Price | 1.485 |
| Earnings Yield | -240.4% |